Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4466016
Max Phase: Preclinical
Molecular Formula: C45H55F3IN7O6S
Molecular Weight: 1005.94
Molecule Type: Unknown
Associated Items:
ID: ALA4466016
Max Phase: Preclinical
Molecular Formula: C45H55F3IN7O6S
Molecular Weight: 1005.94
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCNCCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1
Standard InChI: InChI=1S/C45H55F3IN7O6S/c1-27-40(63-26-52-27)29-13-11-28(12-14-29)24-51-43(60)36-23-31(57)25-56(36)44(61)41(45(2,3)4)54-37(58)10-7-5-6-8-19-50-20-9-21-62-55-42(59)32-16-17-33(46)38(48)39(32)53-35-18-15-30(49)22-34(35)47/h11-18,22,26,31,36,41,50,53,57H,5-10,19-21,23-25H2,1-4H3,(H,51,60)(H,54,58)(H,55,59)/t31-,36+,41-/m1/s1
Standard InChI Key: PEVXBQSIOPXVET-KSEFXOEKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1005.94 | Molecular Weight (Monoisotopic): 1005.2931 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wei J, Hu J, Wang L, Xie L, Jin MS, Chen X, Liu J, Jin J.. (2019) Discovery of a First-in-Class Mitogen-Activated Protein Kinase Kinase 1/2 Degrader., 62 (23): [PMID:31730343] [10.1021/acs.jmedchem.9b01528] |
2. Hu J,Wei J,Yim H,Wang L,Xie L,Jin MS,Kabir M,Qin L,Chen X,Liu J,Jin J. (2020) Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders., 63 (24.0): [PMID:33284613] [10.1021/acs.jmedchem.0c01609] |
Source(1):